Psychedelic Conversations | Jeremy Caudill - Psychedelics For Neurological Trauma #47

Welcome to the Psychedelic Conversations Podcast!

Episode 47:
In this episode, we sit down with Jeremy Caudill to discuss his story of how he survived two ischemic strokes, the use of psychedelics to aid his recovery, thoughts on the psychedelic renaissance, and forming his company "Ninnion Psychedelics".

00:00 - Fire Moment
01:16 - Introduction
02:39 - Jeremy's Story
08:18 - The Psychedelic That Aided Jeremy's Recovery
10:19 - Is Longterm Recovery Possible?
13:07 - Thoughts On The Psychedelic Renaissance
17:50 - Is A Mystical Experience Needed For Recovery?
23:11 - Jeremy's Thoughts On The Group Process
28:26 - The Formation Of "Ninnion Psychedelics"
31:31 - Teaming Up With Rick Strassman
34:38 - Legal Challenges For Ninnion Psychedelics
37:03 - Is Microdosing A Safer Approach?
38:12 - Plans To Work With Other Psychedelics
39:55 - Jeremy's Last Words
42:31 - Outro

About Jeremy:
Jeremy Caudill, CEO, and Founder of Ninnion Psychedelics, a survivor of traumatic brain injury who found solace in psychedelics.

He was diagnosed with a life-threatening aortic aneurysm and heart valve defect and underwent emergency open-heart surgery in 2017. Immediately following, he suffered two ischemic strokes which led to a long and painful post-surgical recovery period.

During this recovery time, Jeremy applied his previous biotech experience to researching pharmaceutical approaches to healing the brain. His exploration of neurogenesis, neuroplasticity and the mechanisms of recovery from traumatic brain injury led him to studies on the efficacy of psychedelics in managing chronic pain and treating severe mental illness.

Ninnion is a pharmaceutical company on a mission to build a fully integrated pharmaceutical psychedelics eco-system leveraging the latest AI drug discovery, development, cGMP manufacturing, commercialization, patient clinics, and specialty pharmacy distribution network designed for the next frontier of psychedelic medicine. Focused on the payer-reimbursed market, Ninnion has begun developing a pipeline of next-generation psychedelic therapies with a clinical focus on brain injury, chronic pain, inflammation, and addiction disorders.

Connect with Jeremy:
Ninnion Website: https://ninnion.com/
Ninnion Twitter: https://twitter.com/ninnionthera
Ninnion Instagram: https://www.instagram.com/ninniontherapeutics/
Ninnion Linkedin: https://www.linkedin.com/company/ninnion-therapeutics/

Thank you so much for joining us!

Psychedelic Conversations Podcast is designed to educate, inform, and expand awareness.

For more information, please head over to https://www.psychedelicconversations.com

Please share with your friends or leave a review so that we can reach more people and feel free to join us in our private Facebook group to keep the conversation going. https://www.facebook.com/groups/psychedelicconversations

This show is for information purposes only and is not intended to provide mental health or medical advice.

About Susan Guner:
Susan is a trained somatic, trauma-informed holistic psychotherapist with a mindfulness-based approach grounded in Transpersonal Psychology that focuses on holistic perspective through introspection, insight, and empathetic self-exploration to increase self-awareness, allowing the integration of the mind, body and spirit aspects of human experience in personal growth and development.

Connect with Susan:
Website: https://www.psychedelicconversations.com/
Facebook: http://www.facebook.com/susan.guner
LinkedIn: https://www.linkedin.com/in/susan-guner/
Instagram: http://www.instagram.com/susanguner\
Twitter: http://www.twitter.com/susanguner
Blog: https://susanguner.medium.com/

#PsychedelicConversations #SusanGuner #JeremyCaudill